Aevis Victoria SA (SWX:AEVS)
Switzerland · Delayed Price · Currency is CHF 13.00
0.00 (0.00%)
At close: Nov 28, 2025
Aevis Victoria Revenue
Aevis Victoria had revenue of 535.89M CHF in the half year ending June 30, 2025, with 25.21% growth. This brings the company's revenue in the last twelve months to 955.96M, up 10.12% year-over-year. In the year 2024, Aevis Victoria had annual revenue of 883.16M with 6.02% growth.
Revenue (ttm)
955.96M
Revenue Growth
+10.12%
P/S Ratio
1.15
Revenue / Employee
202.06K
Employees
4,731
Market Cap
1.10B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 883.16M | 50.15M | 6.02% |
| Dec 31, 2023 | 833.02M | -133.85M | -13.84% |
| Dec 31, 2022 | 966.86M | 221.95M | 29.79% |
| Dec 31, 2021 | 744.92M | 119.97M | 19.20% |
| Dec 31, 2020 | 624.94M | 1.75M | 0.28% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Roche Holding AG | 63.49B |
| Novartis AG | 44.95B |
| Sandoz Group AG | 8.42B |
| Alcon | 8.12B |
| Lonza Group AG | 7.09B |
| Galenica AG | 4.03B |
| Sonova Holding AG | 3.85B |
| Galderma Group AG | 3.73B |
Aevis Victoria News
- 2 months ago - Aevis Victoria SA (XSWX:AEVS) Half Year 2025 Earnings Call Highlights: Strong Growth and ... - GuruFocus
- 2 months ago - Half Year 2025 Aevis Victoria SA Earnings Call Transcript - GuruFocus